A New Dawn in Oncology: FDA Approves Daraxonrasib, Doubling Survival in Metastatic Pancreatic Cancer
Executive Overview In a historic milestone for clinical oncology, the U.S. Food and Drug Administration (FDA) has granted…
#dawn
2 Articles
Executive Overview: The Dawn of a New Flagship Era
In the high-stakes theater of the global automotive industry, few segments carry the prestige, profit margins, and symbolic…
